Skip to content

The effect of collagen-containing supplementation on pain, quality of life and functional parameters in meniscopathy patients

The effect of supplementation with type I and type III collagen peptide and type II hydrolysed collagen on pain, quality of life and physical function in patients with meniscopathy: a randomised, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240411061470N2
Enrollment
35
Registered
2024-05-14
Start date
2024-01-15
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tear of meniscus. Tear of meniscus, current injury

Interventions

Intervention 1: Intervention group: Participants used one sachet of Naturagen® 4 Joint product daily for 8 weeks. This product contained 15 stick sachets of 5.75 grams in a box. Naturagen® 4 Joint con

Sponsors

Ondokuz Mayis University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of unilateral or bilateral grade 1 or 2 meniscal tear for more than 3 months No history of any serious acute trauma to the knee No X-ray or MRI evidence of osteoarthritis Non-vegetarian Willingness to participate in all visits and tests foreseen for the study

Exclusion criteria

Exclusion criteria: Any history of trauma, fracture or surgery on the index joint Evidence or history of clinically significant hematologic, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurologic diseases or malignancies within the last 5 years Active viral or bacterial infection according to clinical examination Knee surgery within the last 12 months or planned surgery within the working period Intra-articular injections (cortisol, hyaluronic acid, etc.) within the last 6 months Taking supplements such as hydrolyzed collagen, glucosamine or chondroitin in the last 6 months Intolerance to protein-based foods or supplements, pregnant or breastfeeding, and alcohol dependence

Design outcomes

Primary

MeasureTime frame
Pain Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Western Ontario and McMaster Universities Osteoarthrtis Index (WOMAC), Visual Analogue Scale (VAS).;Quality of Life Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Oxford Knee Score (OKS), Lower Extremity Functional Scale (LEFS), Tampa Scale for Kinesiophobia (TSK), Short Form Health Survey (SF-12), Foot Function Index (FFI).;Balance Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Berg Balance Scale (BBS).;Functional Performance Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Timed Up and Go (TUG), 6-Minute Walking Test (6MWT), The Five Repetition Sit to Stand Test (5STS), Stair-Climbing Test (SCT).;Proprioception Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Angle measurement with digital goniometer in prone and supine position.;Back and Leg Strength Assessment. Timepoint: Pre-intervention and after 8 weeks of intervention. Method of measurement: Isometric back and leg strength measurement on a dynamometer stand.

Countries

Turkey

Contacts

Public ContactAli Kerim Yilmaz

Ondokuz Mayis University, Faculty of Yasar Dogu Sport Sciences

akerim.yilmaz@omu.edu.tr+90 362 457 76 00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026